ScoreWhy is Sanofi Consumer Healthcare India Ltd ?
1
High Management Efficiency with a high ROE of 76.98%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
The company has declared Positive results for the last 3 consecutive quarters
- NET SALES(Latest six months) At Rs 480.20 cr has Grown at 39.88%
- PAT(Q) Highest at Rs 67.80 cr.
- EPS(Q) Highest at Rs 29.48
4
Technical trend is Sideways signifying no clear price momentum
- The technical trend has deteriorated from Mildly Bullish on 21-May-26 and has generated -1.66% returns since then
5
With ROE of 98.4, it has a Very Expensive valuation with a 41.5 Price to Book Value
- Over the past year, while the stock has generated a return of -7.51%, its profits have risen by 0% ; the PEG ratio of the company is 2.6
6
High Institutional Holdings at 20.33%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sanofi Consumer for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Sanofi Consumer
-22.61%
-0.19
38.61%
Sensex
-11.8%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.10%
EBIT Growth (5y)
5.70%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.98
Sales to Capital Employed (avg)
2.77
Tax Ratio
25.53%
Dividend Payout Ratio
71.85%
Pledged Shares
0
Institutional Holding
20.46%
ROCE (avg)
-178.66%
ROE (avg)
67.74%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
36
Price to Book Value
21.57
EV to EBIT
23.27
EV to EBITDA
22.40
EV to Capital Employed
898.39
EV to Sales
8.32
PEG Ratio
1.89
Dividend Yield
2.09%
ROCE (Latest)
2862.50%
ROE (Latest)
69.27%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET SALES(9M)
At Rs 715.90 cr has Grown at 26.89%
PAT(Q)
Highest at Rs 68.80 cr.
EPS(Q)
Highest at Rs 29.91
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Sanofi Consumer
Profit After Tax (PAT) - Quarterly
Highest at Rs 68.80 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Nine Monthly
At Rs 715.90 cr has Grown at 26.89%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 29.91
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Sanofi Consumer
Non Operating Income - Quarterly
Highest at Rs 6.30 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
